Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, announced that it has entered into an agreement...
FogPharma®, a clinical-stage biopharmaceutical company dedicated to delivering a new class of therapies that go beyond the limits of currently available medicines using its...
